Researchers studied the effect of a second primary melanoma on overall survival among patients with a previous cutaneous or non-cutaneous melanoma.

HealthDay News — Commonly used noncancer medications, including proton pump inhibitors, are associated with poorer survival and adverse events for patients with breast cancer, according to a study ...

Pemigatinib was well-tolerated among patients with CCA regardless of presence of CUP, but HCRU costs were higher with CUP vs without CUP.

Cardiac testing identified asymptomatic, clinically significant arrhythmias in 19% of patients on ibrutinib.

Perioperative enfortumab vedotin and pembrolizumab added to surgery may represent a new standard of care in this population with a high unmet medical need,” said Christof Vulsteke, MD, PhD.

In this study, researchers examined associations between multiple primary cancer incidence and county-level smoking prevalence.